Analyst Ratings for MiNK Therapeutics (INKT) [Buys]
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/10/2022 | H.C. Wainwright | Emily Bodnar | New Coverage | Buy (N/A) |
7.00 (N/A) |
1.32 (0.87) |
-34.09% | Details |
| 11/9/2021 | William Blair | Matt Phipps | New Coverage | Outperform (N/A) |
N/A (N/A) |
18.96 (0.87) |
-95.41% | Details |
 |
||||||||
|
||||||||
